Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Entrepreneurship Guest Lecture Series

Publication date: Aug 28, 2012 02:09 PM

Start: Oct 04, 2012 05:15 PM

[image reference is broken]

Speaker: Rob Fitzpatrick - Technology Entrepreneur / Founder, 10k Bootstrap Challenge, Centric and dex.io
Rob is a tech entrepreneur based in London. He has successfully bankrupted 3 companies, is a Y Combinator alum (summer 07), and has built products used globally by brands like MTV & Sony. He’s raised funding in the US & UK.

He mentors and and teaches at Seedcamp, HackFwd, Emerge, and UCL via Founder Centric.